howdy, capt........supposed to get first/interim data for Insight-004 collaboration with pfizer/merck kgaa...
Combo trial with bavencio/avastin in Germany...I note first patient dosed 6th june this year...
also something to consider re:milestone payments.....
I note...Novartis are putting together 5 ph2 trials with imp701/ lag-525.....given that after GSK's recent
payment was attributed to ph2 first dosage of imp731 I think we can safely assume that Immutep SA's
outlicencing agreements involved payments on first dosage in specific phase trials.....ergo there is a
possibility of another m/s payment from novartis.....
left field news? .....dunno.....
howdy, capt........supposed to get first/interim data for...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.3¢ |
Change
-0.003(0.77%) |
Mkt cap ! $475.7M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.0¢ | 32.0¢ | $299.7K | 924.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 197209 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 116111 | 30 |
View Market Depth
| Last trade - 12.26pm 01/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |